“Attempts to reduce this variation through clear guidelines and standardization may avoid confusion among referring physicians and patients, improve allocation of limited imaging resources, and reduce inconvenience to patients," wrote lead author Bhavika K. Patel, MD, of the Mayo Clinic in Phoenix, and colleagues in a recent study published in the Journal of the American College of Radiology. 

“Because breast parenchyma may reflect the biologic risk factors associated with breast cancer development, yielding the stromal parenchyma as an indicator of precancer, the combination of parenchyma and tumor characteristics may provide a stronger predictive model of malignancy,” lead author Hui Li, PhD, and colleagues wrote in a new study published in Radiology. 

Since 1989, the combination of mammography and improved breast cancer treatment has averted hundreds of thousands of breast cancer mortalities for U.S. women, according to new research published online Feb. 11 in the journal Cancer.

“This case emphasized the importance of a high index of suspicion in an unusual presentation of a common disease and the pivotal role of bronchoscopic intervention in malignant central airway obstruction,” Abdul Hanif Khan, MD, and colleagues wrote, in a new case report published by The BMJ.

A group of researchers from the Republic of Korea found the 2018 Liver Imaging and Reporting Data System (LI-RADS) could accurately differentiate hepatocellular carcinoma (HCC) from other malignancy in patients with liver cirrhosis, according to a study published Jan. 29 in Radiology.

A novel MRI approach developed by researchers from Austria showed promise for non-invasively measuring hypoxia and neovascularization in breast tumors, according to a Jan. 24 article published by Physicsworld.

A test that measures changes in a patients’ blood protein levels through blood samples, brain imaging and cognitive tests could detect Alzheimer's up to 16 years before symptoms appear, according to new research published online in Nature Medicine.

Implementing three-dimensional (3D) digital breast tomosynthesis (DBT) with standard digital mammography (DM) can reduce the number of patients committed to short-term follow-up screening, according to research published online Jan. 19 in Academic Radiology.